Umbilical cord mesenchymal stem cell transplantation for the treatment of Duchenne muscular dystrophy
查看参考文献25篇
文摘
|
Due to their relative abundance,stable biological properties and excellent reproductive activity,umbilical cord mesenchymal stem cells have previously been utilized for the treatment of Duchenne muscular dystrophy,which is a muscular atrophy disease.Three patients who were clinically and pathologically diagnosed with Duchenne muscular dystrophy were transplanted with umbilical cord mesenchymal stem cells by intravenous infusion,in combination with multi-point intramuscular injection.They were followed up for 12 months after cell transplantation.Results showed that clinical symptoms significantly improved,daily living activity and muscle strength were enhanced,the sero-enzyme,electromyogram,and MRI scans showed improvement,and dystrophin was expressed in the muscle cell membrane.Hematoxylin-eosin staining of a muscle biopsy revealed that muscle fibers were well arranged,fibrous degeneration was alleviated,and fat infiltration was improved.These pieces of evidence suggest that umbilical cord mesenchymal stem cell transplantation can be considered as a new regimen for Duchenne muscular dystrophy. |
来源
|
Neural Regeneration Research
,2011,6(10):785-789 【核心库】
|
DOI
|
10.3969/j.issn.1673-5374.2011.10.011
|
关键词
|
umbilical cord mesenchymal stem cells
;
Duchenne muscular dystrophy
;
case report
;
dystrophin
;
muscular force
;
activities of daily living
|
地址
|
Cell Treatment Center,Chinese PLA 463 Hospital, Liaoning, Shenyang, 110042
|
语种
|
英文 |
文献类型
|
简报 |
ISSN
|
1673-5374 |
学科
|
中国医学 |
基金
|
Key Projects of Liaoning Province
|
文献收藏号
|
CSCD:4258073
|
参考文献 共
25
共2页
|
1.
Emery AE. Population frequencies of inherited neuromuscular diseases--a world survey.
Neuromuscul Disord,1991,1(1):19-29
|
CSCD被引
30
次
|
|
|
|
2.
Hoffman EP. Dystrophin:the protein product of the Duchenne muscular dystrophy locus.
Cell,1987,51(6):919-928
|
CSCD被引
37
次
|
|
|
|
3.
Fu YS. Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro:potential therapeutic application for Parkinsonism.
Stem Cells,2006,24(1):115-124
|
CSCD被引
15
次
|
|
|
|
4.
Lu LL. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis supportive function and other potentials.
Haematologica,2006,91(8):1017-1026
|
CSCD被引
42
次
|
|
|
|
5.
Sarugaser R. Human umbilical cord perivascular(HUCPV)cells:a source of mesenchymal progenitors.
Stem Cells,2005,23(2):220-229
|
CSCD被引
82
次
|
|
|
|
6.
Covas DT. Isolation and culture of umbilical vein mesenchymal stem cells.
Braz J Med Biol Res,2003,36(9):1179-1183
|
CSCD被引
32
次
|
|
|
|
7.
Romanov YA. Searching for alternative sources of postnatal human mesenchymal stem cells:candidate MSC-like cells from umbilical cord.
Stem Cells,2003,21(1):105-110
|
CSCD被引
123
次
|
|
|
|
8.
Kadner A. Human umbilical cord cells for cardiovascular tissue engineering:a comparative study.
Eur J Cardiothorac Surg,2004,25(4):635-641
|
CSCD被引
18
次
|
|
|
|
9.
Qiao C. Human mesenchymal stem cells isolated from the umbilical cord.
Cell Biol Int,2008,32(1):8-15
|
CSCD被引
47
次
|
|
|
|
10.
Kim JW. Mesenchymal progenitor cells in the human umbilical cord.
Ann Hematol,2004,83(12):733-738
|
CSCD被引
12
次
|
|
|
|
11.
Conconi MT. CD105(+)cells from Wharton’s jelly show in vitro and in vivo myogenic differentiative potential.
Int J Mol Med,2006,18(6):1089-1096
|
CSCD被引
29
次
|
|
|
|
12.
Can A. Concise review:human umbilical cord stroma with regard to the source of fetus-derived stem cells.
Stem Cells,2007,25(11):2886-2895
|
CSCD被引
49
次
|
|
|
|
13.
Lin XB. Differentiation of human umbilical cord-derived mesenchymal stem cells into cardiomyocytes.
Shiyong Erke Linchuang Zazhi,2007,22(13):971-973
|
CSCD被引
4
次
|
|
|
|
14.
Weiss ML. Human umbilical cord matrix stem cells:preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
Stem Cells,2006,24(3):781-792
|
CSCD被引
84
次
|
|
|
|
15.
Huard J. Muscle-derived stem cells:Potential for muscle regeneration.
Birth Defects Res C,2003,69:230-237
|
CSCD被引
3
次
|
|
|
|
16.
Lee-Pullen TF. Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice.
Transplantation,2004,78(8):1172-1176
|
CSCD被引
8
次
|
|
|
|
17.
Ichim TE. Mesenchymal stem cells as anti-inflammatories:implications for treatment of Duchenne muscular dystrophy.
Cell Immunol,2010,260(2):75-82
|
CSCD被引
7
次
|
|
|
|
18.
Bellantuono I. Haemopoietic stem cells.
Int J Biochem Cell B,2004,36:607-620
|
CSCD被引
9
次
|
|
|
|
19.
Lakshmipathy U. Stem cell plasticity.
Blood Rev,2005,19:29-38
|
CSCD被引
5
次
|
|
|
|
20.
Sampaolesi M. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs.
Nature,2006,444(7119):574-579
|
CSCD被引
8
次
|
|
|
|
|